Eurycomanone and eurycomanol from Eurycoma longifolia jack as regulators of signaling pathways involved in proliferation, cell death and inflammation

by Chateauvieux, S., Choo, C.-Y, Dicato, M., Diederich, M., Hajjouli, S., Orlikova, B., Schumacher, M., Teiten, M.-H
Published 2014

Significant association of increased PD-L1 and PD-1 expression with nodal metastasis and a poor prognosis in oral squamous cell carcinoma

by Goto, Y., Hashiguchi, Y., Jinno, T., Kaneko, N., Kawano, S., Kitamura, R., Kiyoshima, T., Maruse, Y., Matsubara, R., Moriyama, M., Nakamura, S., Oobu, K., Sakamoto, T., Tanaka, H., Toyoshima, T.
Published 2018

Beyond the bucket list: Unfinished and business among advanced cancer patients

by Breitbart, W., Holland, J., Jankauskaite, G., Lichtenthal, W.G, Masterson, M.P, Pessin, H., Schofield, E., Slivjak, E.
Published 2018

Pembrolizumab and Trastuzumab in High Tumor Mutational Burden and POLE-Mutated HER2-Positive Refractory Breast Cancer

by Chen, Y., Jiao, S., Lv, Y., Zhang, L., Zhao, W.
Published 2022

Inhibitory Effects of Raw-Extract Centella asiatica (RECA) on Acetylcholinesterase, Inflammations, and Oxidative Stress Activities via in Vitro and in Vivo

by Adenan, M.I, Hafiz, Z.Z, Johari James, R.M, Mohd Amin, M.A, Salleh, M.Z, Teh, L.K
Published 2020

Dysregulated ferroptosis-related genes indicate potential clinical benefits for anti–PD-1/PD-L1 immunotherapy in lung adenocarcinoma

by Chen, Y., Li, T., Zhang, X., Zhou, M.
Published 2021

Long-term avelumab in advanced non-small-cell lung cancer: Summaries and post hoc analyses from JAVELIN Solid Tumor

by Bajars, M., Bennouna, J., Goel, S., Gulley, J.L, Hrinczenko, B., Iannotti, N., Kelly, K., Manitz, J., Ruisi, M., Safran, H., Spigel, D., Taylor, M.H, Verschraegen, C., Wong, D.J
Published 2022

Predictive biomarkers for the efficacy of nivolumab as ≥ 3rd-line therapy in patients with advanced gastric cancer: a subset analysis of ATTRACTION-2 phase III trial

by Kang, Y.-K, Kim, D., Kim, J.H, Lee, S.Y, Ma, J., Park, Y.S, Ryu, M.-H
Published 2022

Bayesian calibration of a stochastic, multiscale agent-based model for predicting in vitro tumor growth

by Faghihi, D., Lima, E.A.B.F, Philley, R., Phillips, C.M, Virostko, J., Yang, J., Yankeelov, T.E
Published 2021

Influence of tumor mutational burden, inflammatory gene expression profile, and PD-L1 expression on response to pembrolizumab in head and neck squamous cell carcinoma

by Albright, A., Ayers, M., Burtness, B., Cheng, J., Chow, L.Q.M, Cristescu, R., Eder, J.P, Gluck, I., Gupta, S., Haddad, R.I, Huang, L., Kang, H., Keam, B., Lunceford, J., Mehra, R., Mogg, R., Muro, K., Seiwert, T.Y, Tahara, M., Weiss, J.
Published 2022

Ascites and resistance to immune checkpoint inhibition in dMMR/MSI-H metastatic colorectal and gastric cancers

by Ambrosini, M., Andre, T., Bergamo, F., Chao, J., Chida, K., Cohen, R., Colle, R., Conca, V., Corti, F., Cremolini, C., Curigliano, G., Elez, M.E, Emmett, M., Fakih, M., Fenocchio, E., Fucà, G., Garciá, M.D, Jayachandran, P., Kawazoe, A., Klempner, S.J, Lonardi, S., Mazzoli, G., Overman, M., Pietrantonio, F., Provenzano, L., Randon, G., Salati, M., Salvatore, L., Shah, A.T, Shitara, K., Svrcek, M.
Published 2022

Clinical evaluation of a laboratory-developed test using clone E1L3N for the detection of PD-L1 expression status in non-small cell lung cancer

by Chen, C., Chen, G., Dong, X., Hou, T., Li, Y., Xu, H., Ye, J., Zhao, H.
Published 2021

Systemic high-dose dexamethasone treatment may modulate the efficacy of intratumoral viral oncolytic immunotherapy in glioblastoma models

by Aguilar, E., Aguilar, L.K, Barone, F., Chiocca, E.A, Griffith, A.M, Guzik, B.W, Koch, M.S, Lawler, S., Lederer, J.A, Nowicki, M.O, Tabatabai, G., Tak, P.P, Zdioruk, M.
Published 2022

Gamma-tocotrienol acts as a BH3 mimetic to induce apoptosis in neuroblastoma SH-SY5Y cells

by Jamal, R., Mazlan, M., Raja Abdul Rahman, R.N.Z, Tan, J.-K, Then, S.-M, Wan Ngah, W.Z
Published 2016

Nivolumab vs investigator's choice in recurrent or metastatic squamous cell carcinoma of the head and neck: 2-year long-term survival update of CheckMate 141 with analyses by tumor...

by Blumenschein, G., Jr, Colevas, A.D, Docampo, L.C.I, Even, C., Fayette, J., Ferris, R.L, Gillison, M.L, Guigay, J., Haddad, R., Harrington, K.J, Jayaprakash, V., Kasper, S., Kiyota, N., Li, L., Licitra, L., Lynch, M., Rordorf, T., Saba, N.F, Tahara, M., Vokes, E.E, Worden, F.
Published 2018

Method of Tumor Pathological Micronecrosis Quantification Via Deep Learning from Label Fuzzy Proportions

by Bai, X., Ge, H., Li, J., Liang, T., Lu, N., Tian, Y., Wu, J., Ye, Q., Zhang, Q., Zhou, T.
Published 2021

USP21 promotes cell proliferation by maintaining the EZH2 level in diffuse large B-cell lymphoma

by He, N., Liu, M., Luo, X., Ma, H., Xie, W., Zhou, J., Zhou, P.
Published 2021

New developments and clinical transition of hyaluronic acid-based nanotherapeutics for treatment of cancer: reversing multidrug resistance, tumour-specific targetability and improv...

by Abourehab, M.A.S, Afzal, S., Hasan, H., Hussain, Z., Safdar, M.H, Thu, H.E
Published 2018

Immune checkpoints indoleamine 2,3-dioxygenase 1 and programmed death-ligand 1 in oral mucosal dysplasia

by Almahmoudi, R., Al-Samadi, A., Christopher, S., Passador-Santos, F., Salo, T., Sieviläinen, M., Siponen, M., Toppila-Salmi, S.
Published 2018

mRNA microarray profiling identifies a novel circulating HTRA2 for detection of gastric cancer

by Chen, X., Cheng, Y., Li, X., Lv, C., Sun, G., Tang, W., Wu, F., Wu, L., Zhang, W.
Published 2021